Answers are grounded in this paper and cite their sources.
Staging systems are used to predict the clinical and biologic behavior of tumors. This manuscript examines several molecular markers that hope to improve staging for colon cancer. It is unclear if a molecular marker, genetic signature, or a combination of histologic, genetic, and molecular parameters will provide the best prognostic information. What is clear is that more accurate staging tools are needed so patients receive the best therapy.
No takes yet. Share an insight, caveat, or question.
Matthew G. Mutch (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: